Terms: = Lymphoma AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791 AND Treatment
6 results:
1. End-of-Life Care for Older Adults with Aggressive Non-Hodgkin lymphoma.
Johnson PC; Markovitz NH; Yi A; Newcomb RA; Amonoo HL; Nelson AM; Reynolds MJ; Rice J; Lavoie MW; Odejide OO; Nipp RD; El-Jawahri A
J Palliat Med; 2022 May; 25(5):728-733. PubMed ID: 34724798
[No Abstract] [Full Text] [Related]
2. The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.
Kaufman KL; Jenkins Y; Alomari M; Mirzaei M; Best OG; Pascovici D; Mactier S; Mulligan SP; Haynes PA; Christopherson RI
Oncotarget; 2015 Dec; 6(38):40981-97. PubMed ID: 26556860
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture.
Mitsui T; Ishida M; Izawa M; Kagami Y; Arita J
Mol Cell Endocrinol; 2011 Oct; 345(1-2):68-78. PubMed ID: 21787835
[TBL] [Abstract] [Full Text] [Related]
4. Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
Du J; Huo J; Shi J; Yuan Z; Zhang C; Fu W; Jiang H; Yi Q; Hou J
Haematologica; 2011 May; 96(5):729-37. PubMed ID: 21228035
[TBL] [Abstract] [Full Text] [Related]
5. Primary tumors of the mediastinum.
Whooley BP; Urschel JD; Antkowiak JG; Takita H
J Surg Oncol; 1999 Feb; 70(2):95-9. PubMed ID: 10084651
[TBL] [Abstract] [Full Text] [Related]
6. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/lyt-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract] [Full Text] [Related]
